Trials / Conditions / Paroxysmal Hemoglobinuria, Nocturnal
Paroxysmal Hemoglobinuria, Nocturnal
4 registered clinical trials studyying Paroxysmal Hemoglobinuria, Nocturnal.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Active Not Recruiting | Study to Assess Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of Crovalimab in Healthy Volunteers a NCT03157635 | Hoffmann-La Roche | Phase 1 / Phase 2 |
| Completed | Eculizumab to Treat Paroxysmal Nocturnal Hemoglobinuria NCT00130000 | National Heart, Lung, and Blood Institute (NHLBI) | Phase 3 |
| Completed | Extension Study of Eculizumab in Patients With Transfusion Dependent Paroxysmal Nocturnal Hemoglobinuria (PNH) NCT00122317 | Alexion Pharmaceuticals, Inc. | Phase 3 |
| Completed | Study of High Dose Cyclophosphamide in Patients With Severe Aplastic Anemia and Paroxysmal Nocturnal Hemoglobi NCT00004464 | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Phase 2 |